Evidence map›Paper›PMID 33803782›Full record

ReviewNanomaterials (Basel, Switzerland)2021

An Overview of Recent Advances in the Synthesis and Applications of the Transition Metal Carbide Nanomaterials.

Saba Ahmad, Iffat Ashraf, Muhammad Adil Mansoor, Syed Rizwan, Mudassir Iqbal

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saba AhmadDepartment of Chemistry, School of Natural Sciences, National University of Sciences and Technology (NUST), H-12, Islamabad 44000, Pakistan.
Iffat AshrafDepartment of Chemistry, School of Natural Sciences, National University of Sciences and Technology (NUST), H-12, Islamabad 44000, Pakistan.
Muhammad Adil MansoorDepartment of Chemistry, School of Natural Sciences, National University of Sciences and Technology (NUST), H-12, Islamabad 44000, Pakistan.
Syed RizwanPhysics Characterization and Simulations Lab (PCSL), Department of Physics, School of Natural Sciences, National University of Sciences and Technology (NUST), H-12, Islamabad 44000, Pakistan.
Mudassir IqbalDepartment of Chemistry, School of Natural Sciences, National University of Sciences and Technology (NUST), H-12, Islamabad 44000, Pakistan.ORCID 0000-0002-9830-8235

Funding

Higher Education Commission Pakistan 6040/Federal/NRPU/R&D/HEC/2016.United States Agency for International Development HEC/R&D/PAKUS/2017/783
6 · The paper itself

Abstract

Good stability and reproducibility are important factors in determining the place of any material in their respective field and these two factors also enable them to use in various applications. At present, transition metal carbides (TMCs) have high demand either in the two-dimensional (2D) form (MXene) or as nanocomposites, nanoparticles, carbide films, carbide nano-powder, and carbide nanofibers. They have shown good stability at high temperatures in different environments and also have the ability to show adequate reproducibility. Metal carbides have shown a broad spectrum of properties enabling them to engage the modern approach of multifacet material. Several ways have been routed to synthesize metal carbides in their various forms but few of those gain more attention due to their easy approach and better properties. TMCs find applications in various fields, such as catalysts, absorbents, bio-sensors, pesticides, electrogenerated chemiluminescence (ECL), anti-pollution and anti-bacterial agents, and in tumor detection. This article highlights some recent developments in the synthesis methods and applications of TMCs in various fields.

Indexed as

biosensorenergy storagesynthesisTMCswater splitting

Identifiers

PMID33803782
PMCPMC8003216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.